लोड हो रहा है...
NHDL, a recombinant V(L)/V(H) hybrid antibody control for IgG2/4 antibodies
The mechanism of action of recombinant IgG2/4 antibodies involves blocking of their target without the induction of effector functions. Examples are eculizumab (Soliris®), which is used clinically to block complement factor C5, as well as anti-human CD14 (r18D11) and anti-porcine CD14 (rMIL2) produc...
में बचाया:
| में प्रकाशित: | MAbs |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Taylor & Francis
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927768/ https://ncbi.nlm.nih.gov/pubmed/31671278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1686319 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|